Healthcare -
Biotechnology - NASDAQ - US
$ 313.0
-2.2 %
$ 14.1 B
Market Cap
12.7
P/E
UTHR - REVENUE
Revenue UTHR - United Therapeutics Corporation
2.33 B
LAST VALUE
17.51%
2 YEAR CAGR
7.41%
5 YEAR CAGR
7.62%
10 YEAR CAGR